Increased saturated triacylglycerol levels in plasma membranes of human neutrophils stimulated by lipopolysaccharide.
Neutrophils isolated from patients with bacterial infections or stimulated in vitro with lipopolysaccharide (LPS) produce a high resolution, lipid-dominated spectrum on 1H-NMR spectroscopy (May et al, 1993. J. Infect. Dis. 168: 386-392). We have investigated the origin of this lipid signal using NMR and chemical analyses of both whole neutrophils and purified plasma membranes. Plasma membranes from neutrophils that had been stimulated with 50 microg/ml LPS exhibited the high resolution 1H-NMR signal, and contained double the triacylglycerol (TAG) content of plasma membranes isolated from resting cells. Chemical analysis of the whole cells indicated that the TAG also increased at the cellular level (1.7-fold) after stimulation with LPS. Diradylglycerol increased 2- to 3-fold in both whole cells and plasma membranes after stimulation, but was only a minor component compared with TAG. The plasma membrane protein/phospholipid ratio increased 2.6-fold, whereas cholesterol (free and esterified) was unchanged. The membranes from LPS-stimulated neutrophils exhibited increased fluidity, as judged by increased merocyanine 540 binding, consistent with a 2-fold reduction in cholesterol/phospholipid ratio. LPS induced a shift in fatty acid content of whole cell polar lipids towards more oleic acid and less palmitic acid, whereas the neutral lipid fraction contained increased amounts of palmitic and stearic acids. The TAG fraction of plasma membrane lipids contained increased amounts of palmitic acid when prepared from cells stimulated with LPS. We conclude that the 1H-NMR signal in LPS-stimulated neutrophils arises from increased amounts of plasma membrane TAG with an elevated content of palmitic acid.
May
G L
GL
Centre for Infectious Diseases and Microbiology, University of Sydney, Westmead Hospital, NSW, Australia.
Wright
L C
LC
Obbink
K G
KG
Byleveld
P M
PM
Garg
M L
ML
Ahmad
Z I
ZI
Sorrell
T C
TC
D002462:Cell Membrane / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D005227:Fatty Acids / Q000097:blood / Q000737:chemistry; D006801:Humans; D066298:In Vitro Techniques; D008070:Lipopolysaccharides / Q000494:pharmacology*; D009682:Magnetic Resonance Spectroscopy; D008560:Membrane Fluidity / Q000187:drug effects; D008563:Membrane Lipids / Q000097:blood* / Q000737:chemistry; D009504:Neutrophils / Q000187:drug effects* / Q000378:metabolism*; D010743:Phospholipids / Q000097:blood / Q000737:chemistry; D014280:Triglycerides / Q000097:blood* / Q000737:chemistry
D005227:Fatty Acids; D008070:Lipopolysaccharides; D008563:Membrane Lipids; D010743:Phospholipids; D014280:Triglycerides